Biological Mechanisms Related to the Effectiveness of Guided Imagery for Chronic Pain

Abstract

Specific aims of this pilot study were to (a) determine the effect of a guided imagery (GI) intervention over an 8-week period on pain and pain disability in a sample of persons with chronic noncancer pain (CNCP) and (b) analyze the mediating effects of neuroendocrine and neuroimmune functioning on the effectiveness of GI on outcome variables. A simple interrupted time-series design (12-week period) was used. GI was introduced at Week 4 and used daily by 25 participants for the remaining 8 weeks. Measures of pain and pain disability were obtained at the beginning of the study period and at six repeated 2-week intervals. Measures of hypothalamic-pituitary-adrenal (HPA) axis activation (plasma cortisol), immune-mediated analgesia (lymphocyte subset counts and proliferation), and immune-mediated hyperalgesia (interleukin-1β) were obtained at the beginning of the study and at Week 11. Usual pain levels were lower after the introduction of GI at Week 4 (Wilks' λ = 52.31; df = 2, 22; p = .000). Pain disability levels were lower after the introduction of GI at Week 4 (Wilks' λ = 5.98; df = 6, 18; p = .001). Correlation coefficients between change scores of dependent variables and mediating variables were not significant. GI was effective in reducing pain intensity and pain disability over an 8-week period; however, the results did not support the expected effects of decreased HPA axis activation, improved immune-mediated analgesia, and reduced immune-mediated hyperalgesia in mediating these outcomes. These findings may be related to procedural and theoretical issues and limitations related to the study design.

Keywords

chronic pain guided imagery hyperalgesia

Get full access to this article

View all access options for this article.

References

Baird

C. L.

Sands

(2004). A pilot study of the effectiveness of guided imagery with progressive muscle relaxation to reduce chronic pain and mobility difficulties of osteoarthritis. Pain Management Nursing, 5, 97–104.

Benson

(1975). The relaxation response. New York, NY: Avon.

Berman

B. M.

Swyers

J. P.

(1998). Applying complementary/alternative medicine approaches to managing chronic pain syndromes: If not now, when? APS Bulletin, 8, 4–6.

Bernstein

I. H.

Jaremko

M. E.

Hinkley

B. S.

(1995). On the utility of the West Haven-Yale Multidimensional Pain Inventory Scale. Spine, 20, 956–963.

Brennan

P. C.

Graham

M. A.

Triano

J. J.

Hondras

M. S.

Anderson

R. J.

(1994). Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial. Journal of Manipulative Physiological Therapeutics, 17, 219–227.

Bussone

Salmaggi

Leone

Valentine

Dufour

Nespolo

(1992). Immunological alterations in cluster headache during remission and cluster period. Comparison with low back pain patients. Cephalagia, 12, 250–253.

Cabot

P. J.

(1999). Immune-derived opioids and peripheral antinociception. Clinical Experiments in Pharmacology and Physiology, 28, 230–232.

Carson

M. G.

Mitchell

G. J.

(1998). The experience of living with persistent pain. Journal of Advanced Nursing, 28, 1242–1248.

Chapman

C. R.

Tuckett

R. P.

Song

C. W.

(2008). Pain and stress in a systems perspective: Reciprocal neural, endocrine, and immune interactions. Journal of Pain, 9, 122–145.

10.

Coe

C. L.

Rosenberg

L. T.

Levine

(1988). Prolonged effect of psychological disturbance on macrophage chemiluminescence in the squirrel monkey. Brain, Behavior, and Immunity, 2, 151–161.

11.

Cohen

(1988). Statistical power analysis for the behavioral sciences. 2nd ed. New York, NY: Lawrence Erlbaum.

12.

Coker

K. H.

(1999). Meditation and prostate cancer: Integrating a mind/body intervention with traditional therapies. Seminars in Urologic Oncology, 17, 111–118.

13.

Cook

T. D.

Campbell

D. T.

(1979). Quasi-experimentation. Design & analysis issues for field settings. Boston, MA: Houghton Mifflin.

14.

Corwin

E. J.

(2000a). Understanding cytokines part I: Physiology and mechanism of action. Biological Research for Nursing, 2, 30–40.

15.

Corwin

E. J.

(2000b). Understanding cytokines part II: Implications for nursing research and practice. Biological Research for Nursing, 2, 41–48.

16.

Davis

G. C.

(1989). The clinical assessment of chronic pain in rheumatic disease: Evaluating the use of two instruments. Journal of Advanced Nursing, 14, 397–402.

17.

Downie

W. W.

Leatham

P. A.

Rhind

V. M.

Wright

Branco

J. A.

Anderson

J. A.

(1978). Studies with pain rating scales. Annals of Rheumatic Disease, 37, 378–381.

18.

Drugan

R. C.

Basile

A. S.

J. H.

Healy

Ferland

R. J.

(1997). Analysis of the importance of controllable versus uncontrollable stress on subsequent behavioral and physiological functioning. Brain Research. Brain Research Protocols, 2, 69–74.

19.

Eller

L. S.

(1999). Guided imagery interventions for symptom management. Annual Review of Nursing Research, 17, 57–84.

20.

Fernandez

Turk

D. C.

(1989). The utility of cognitive coping strategies for altering pain perception: A meta-analysis. Pain, 38, 123–135.

21.

Folstein

McHugh

(1975). Mini-mental state: A practical method for grading cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.

22.

Fors

E. A.

Sexton

Gotestam

K. G.

(2002). The effect of guided imagery and amitriptyline on daily fibromyalgia pain: A prospective, randomized, controlled trial. Journal of Psychiatric Research, 36, 179–187.

23.

Gruzelier

J. H.

(2002). The role of psychological intervention in modulating aspects of immune function in relation to health and well-being. International Review of Neurobiology, 52, 383–417.

24.

Haddad

J. J.

Saade

N. E.

Safieh-Garabedian

(2002). Cytokines and neuro-immune-endocrine interactions: A role for the hypothalamic-pituitary-adrenal revolving axis. Journal of Neuroimmunology, 133, 1–19.

25.

Hansson

(2006). Could chronic pain and spread of pain sensation be induced and maintained by glial activation? Acta Physiology, 187, 321–327.

26.

Harbuz

M. S.

(1999). Chronic inflammatory stress. Balliere’s Clinical Endocrinology and Metabolism, 13, 555–565.

27.

Harbuz

M. S.

Chover-Gonzalez

A. J.

Jessop

D. S.

(2003). Hypothalamo-pituitary-adrenal axis and chronic immune activation. Annals of the New York Academy of Science, 992, 99–106.

28.

Huskisson

E. C.

(1983). Visual analogue scales. In Melzack

(Ed.), Pain measurement and assessment (pp. 33–37). New York, NY: Raven Press.

29.

International Association for the Study of Pain. (1986). Pain terms: A current list with definitions and notes on usage. Pain, 3, S216–S221.

30.

Kerns

R. D.

Turk

D. C.

Rudy

T. E.

(1985). The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain, 23, 345–356.

31.

Kiecolt-Glaser

J. K.

Marucha

P. Y.

Atkinson

Glaser

(2001). Hypnosis as a modulator of cellular immune dysregulation during acute stress. Journal of Consulting and Clinical Psychology, 69, 674–682.

32.

Kiecolt-Glaser

J. K.

McGuire

Robles

R. F.

Glaser

(2002a). Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annual Review of Psychology, 53, 83–107.

33.

Kiecolt-Glaser

J. K.

McGuire

Robles

R. F.

Glaser

(2002b). Psychoneuroimmunology: Psychological influences on immune function and health. Journal of Consulting and Clinical Psychology, 70, 537–547.

34.

Kraemer

H. C.

Wilson

Fairburn

C. G.

Agras

W. S.

(2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry, 59, 877–883.

35.

Kremer

E. F.

Atkinson

J. H.

(1981). Pain measurement: Construct validity for the affective dimension of the McGill Pain Questionnaire with chronic benign pain patients. Pain, 11, 93–100.

36.

Kronfol

Remick

D. G.

(2000). Cytokines and the brain: Implications for clinical psychiatry. American Journal of Psychiatry, 157, 683–694.

37.

Kwekkeboom

(2000). Measuring imaging ability: Psychometric testing of the Imaging Ability Questionnaire. Research in Nursing and Health, 23, 301–309.

38.

LeMay

L. G.

Vander

A. J.

Kluger

M. J.

(1990). The effects of psychological stress on plasma interleukin-6 activity in rats. Physiology and Behavior, 47, 957–961.

39.

Lewandowski

W. A.

(2004a). Patterning of pain and power with guided imagery. Nursing Science Quarterly, 17, 233–241.

40.

Lewandowski

W. A.

(2004b). Psychological factors in chronic pain: A worthwhile undertaking for nursing? Archives in Psychiatric Nursing, 18, 97–105.

41.

Lewandowski

Good

Draucker

(2005). Changes in the meaning of pain with guided imagery. Pain Management Nursing, 6, 58–67.

42.

Lutgendorf

S. K.

Constanzo

E. S.

(2003). Psychoneuroimmunology and health psychology: An integrative model. Brain, Behavior, and Immunity, 17, 225–232.

43.

Maier

S. F.

Watkins

L. R.

(1998). Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review, 105, 83–107.

44.

Mannix

L. K.

Chandurkar

R. S.

Rybicki

L. A.

Tusek

D. L.

Solomon

G .D.

(1998). Effect of guided imagery on quality of life for patients with chronic tension-type headache. Headache, 39, 326–334.

45.

Mayer

Bushnell

M. C.

(2009). Functional pain syndromes: Presentation and pathophysiology. Seattle, WA: IASP Press.

46.

McCain

N. L.

Gray

D. P.

Walter

J. M.

Robins

(2005). Implementing a comprehensive approach to the study of health dynamics using the psychoneuroimmunology paradigm. Advances in Nursing Science, 28, 320–332.

47.

Melzack

(1975). The McGill Pain Questionnaire: Major properties and scoring methods. Pain, 1, 277–299.

48.

Mersky

Bogduk

(1994). Classification of chronic pain. 2nd ed. Seattle, WA: IASP Press.

49.

Moran

K. J.

(1989). The effects of self-guided and other-guided imagery on chronic low back pain. In Funk

S. G.

Tornquist

E. M.

Champagne

M. T.

(Eds.), Key aspects of comfort management of pain, fatigue, and nausea (pp. 160–184). New York, NY: Springer.

50.

Neeck

Crofford

L. J.

(2000). Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheumatic Disease Clinics of North America, 26, 989–1002.

51.

Okifuji

Turk

D.C.

Kalauokalani

(1999). Clinical outcome and economic evaluation of multidisciplinary pain centers. In Block

A. R.

Kremer

E. F.

Fernandez

(Eds.), Handbook of pain syndromes. Biopsychosocial perspectives (pp. 77–98). Mahwah, NJ: Laurence Erlbaum.

52.

Pollard

C. A.

(1984). Preliminary validity study of Pain Disability Index. Perceptual Motor Skills, 59, 974.

53.

Pollmacher

Haack

Schuld

Reichenberg

Yiriya

(2002). Low levels of circulating inflammatory cytokines—Do they affect human brain functions? Brain, Behavior, and Immunity, 16, 525–532.

54.

Price

D. D.

McGrath

P. A.

Rafii

Buckingham

(1983). The validation of visual analogue scales as ratio scale measure for chronic and experimental pain. Pain, 17, 45–56.

55.

Prieto

E. J.

Hopson

Bradley

L. A.

Byrne

Geisinger

K. F.

Midax

Marchisello

P. J.

(1980). The language of low back pain: Factor structure of the McGill Pain Questionnaire. Pain, 8, 11–19.

56.

Raft

Smith

R. H.

Warren

(1986). Selection of imagery in the relief of chronic and acute clinical pain. Journal of Psychosomatic Research, 30, 481–488.

57.

Remer

Maser-Gluth

Wudy

S. A.

(2008). Glucocorticoid measurements in health and disease—Metabolic implications and the potential of 24-h urine analyses. Mini-Reviews in Medicinal Chemistry, 8, 153–170.

58.

Riley

J. L.

Zawacki

T. M.

Robinson

M. E.

Geisser

M. E.

(1999). Empirical test of the factor structure of the West Haven-Yale Multidimensional Pain Inventory. Clinical Journal of Pain, 15, 24–30.

59.

Rohling

M. L.

Binder

L. M.

Langrinrichsen-Rohling

(1995). Money matters: A meta-analytic review of the association between financial compensation and the experience and treatment of chronic pain. Health Psychology, 14, 537–547.

60.

SASSI Institute. (1999). The SASSI-3 manual. Springville, IN: Author.

61.

Savage

S. R.

Joranson

D. E.

Covington

E. C.

Schnoll

S. H.

Heit

H. A.

Gilson

A. M.

(2003). Definitions related to the medical use of opioids: Evolution towards universal agreement. Journal of Pain and Symptom Management, 26, 655–667.

62.

Scott

Huskisson

E. C.

(1976). Graphic representation of pain. Pain, 2, 175–184.

63.

Seers

Friedli

(1996). The patients' experiences of their chronic nonmalignant pain. Journal of Advanced Nursing, 24, 1160–1168.

64.

Shanks

Harbuz

M. S.

Jessop

D. S.

Perks

Moore

P. M.

Mightman

S. L.

(1998). Inflammatory disease as chronic stress. Annals of the New York Academy of Science, 840, 599–607.

65.

Shi

Devadas

Greeneltch

K. M.

Yin

Mufson

R. A.

Zhou

(2003). Stressed to death: Implication of the lymphocyte apoptosis for psychoneuroimmunology. Brain, Behavior, and Immunity, 17, S18–S26.

66.

Stein

(1995). The control of pain in peripheral tissue by opioids. New England Journal of Medicine, 332, 1685–1690.

67.

Stein

Machelska

Binder

Schafer

(2001). Peripheral opioid analgesia. Current Opinions in Pharmacology, 1, 62–65.

68.

Stein

Yassouridis

(1997). Peripheral morphine analgesia. Pain, 71, 119–121.

69.

Strouse

T. B.

(2007). The relationship between cytokines and pain/depression: A review and current status. Current Pain and Headache Reports, 11, 98–103.

70.

Tait

R. C.

Chibnall

J. T.

Krausse

(1990). The Pain Disability Index: Psychometric properties. Pain, 40, 171–182.

71.

Thomas

S. P.

(2000). A phenomenologic study of chronic pain. Western Journal of Nursing Research, 22, 683–705.

72.

Thorn

Hucklebridge

Evans

Clow

(2009). The cortisol awakening response, seasonality, stress and arousal: A study of trait and state influences. Psychoneuroendocrinology, 34, 299–306.

73.

Turk

D. C.

Okifuji

(2002). Psychological factors in chronic pain: Evolution and revolution. Journal of Consulting and Clinical Psychology, 3, 678–690.

74.

Vedhara

Fox

J. D.

Wang

E. C. Y.

(1999). The measurement of stress-related immune dysfunction in psycho-neuroimmunology. Neuroscience Biobehavioral Review, 23, 715.

75.

Vines

S. W.

Gupta

S. W.

Dostal-Johnson

Hummler-Davis

(2003). The relationship between chronic pain, immune function, depression, and health behaviors. Biological Research in Nursing, 5, 18–29.

76.

Watkins

L. R.

Maier

S. F.

(2000). The pain of being sick: Implications of immune-to-brain communication for understanding pain. Annual Review of Psychology, 51, 29–57.

77.

Watkins

L. R.

Maier

S .F.

(2005). Immune regulation of central nervous system functions: From sickness responses to pathological pain. Journal of Internal Medicine, 257, 139–155.

78.

Wieseler-Frank

Maier

S. F.

Watkins

L. R.

(2005). Central proinflammatory cytokines and pain enhancement. Neurosignals, 14, 166–174.